Swapnil S. Lad, Swati U. Kolhe, Omkar A. Devade, Asawari P. Mansabdar
Swapnil S. Lad1*, Swati U. Kolhe2, Omkar A. Devade3, Asawari P. Mansabdar4
1,4M. Pharm Research Scholars, Department of Pharmacology, AISSMS College of Pharmacy, Pune - 411001, Maharashtra, India.
2,3Faculty, Department of Pharmacology, AISSMS College of Pharmacy, Pune - 411001, Maharashtra, India.
Volume - 13,
Issue - 3,
Year - 2023
Since the beginning of time people have used plants as a solution for different infections and/or diseases. With the approach of current synthetic medicines, plant medication has frequently been subjected to the edge of therapeutic modalities. However, it is progressively being recognized that the synthetic therapeutic agents have a few limitations particularly in ongoing chronic illnesses like hyperlipidaemia. Hyperlipidaemia is an ailment characterised by an expansion in at least one of the plasma lipids, including cholesterol, triglycerides, plasma lipoproteins such as low density lipoprotein (LDL) and very low density lipoprotein (VLDL) alongside diminished high-density lipoprotein (HDL) levels. Research is continuous to find more current medications and a few novel helpful targets are being investigated for hyperlipidaemia. In the current review, the types of hyperlipidaemias, lipid metabolism, causes and risk factors of hyperlipidaemia has been explained along side the plant derived bioactiveand extracts that have been demonstrated in the past 15 years to have a potential in treatment of hyperlipidaemia has been discussed.
Cite this article:
Swapnil S. Lad, Swati U. Kolhe, Omkar A. Devade, Asawari P. Mansabdar. Hyperlipidaemia: A Review of Literature. Asian Journal of Pharmaceutical Research. 2023; 13(3):175-0. doi: 10.52711/2231-5691.2023.00033
Swapnil S. Lad, Swati U. Kolhe, Omkar A. Devade, Asawari P. Mansabdar. Hyperlipidaemia: A Review of Literature. Asian Journal of Pharmaceutical Research. 2023; 13(3):175-0. doi: 10.52711/2231-5691.2023.00033 Available on: https://asianjpr.com/AbstractView.aspx?PID=2023-13-3-7
1. Balouiri M., Sadiki M., Ibnsouda S.K. Methods for in vitro evaluating antimicrobial activity: A review. Journal of Pharmaceutical Analysis. 2016; 6(2):71-79. doi: 10.1016/j.jpha.2015.11.005.
2. Coenye T., Nelis H.J. In vitro and in vivo model systems to study microbial biofilm formation. Journal of Microbiological Methods. 2010; 83(2):89-105. doi: 10.1016/j.mimet.2010.08.018.
3. Blaser J., Zinner S.H. In vitro models for the study of antibiotic activities. In: Lorian V. (eds) Antibiotics in Laboratory Medicine. Springer, New York, NY; 1987. pp. 349-381. doi: 10.1007/978-1-4757-0602-4_15.
4. Chauhan N.S. Introductory chapter: human and microbes in health and diseases, role of microbes in human health and diseases. Intech Open; 2019. doi: 10.5772/intechopen.85217.
5. Janeway CA Jr, Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease, The front line of host defense.
6. Dugassa J., & Shukuri N. Review On Antibiotic Resistance And Its Mechanism Of Development. Journal of Health, Medicine and Nursing. 2014; 1(3): 1–17.
7. Jain S, Vyas R, Pandit P, Dalai A. Occurrence and Removal of Antiviral Drugs in Environment: A Review. Water, Air, & Soil Pollution. 2013; 224: 1410-3. doi: 10.1007/s11270-012-1410-3.
8. Vardanyan R., Hruby V. Antiviral Drugs. Synthesis of Best-Seller Drugs. 2016:687–736. doi: 10.1016/B978-0-12-411492-0.00034-1.
9. Tripathi K.D. Essentials of Medical Pharmacology, 7th edition. Jaypee Brothers Medical Publishers (P) Ltd. 2013: 787.
10. Karki N.K., Ahmed A., Charde R., Charde M., & Gandhare B. An Overview On Antifungal Therapy. International Journal of Biomedical and Advance Research. 2011; 2(1): 69–85. doi: 10.7439/ijbar.v2i1.23.
11. Cao C, Qu Y, Sun M, Qiu Z, Huang X, Huai B, Lu Y and Zeng Z. In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves. Frontiers in Microbiology. 2015; 6:759. doi: 10.3389/fmicb.2015.00759
12. You XF, Li CR, Yang XY, Yuan M, Zhang WX, Lou RH, Wang YM, Li GQ, Chen HZ, Song DQ, Sun CH, Cen S, Yu LY, Zhao LX, Jiang JD. In Vivo Antibacterial Activity of Vertilmicin, a New Aminoglycoside Antibiotic. Antimicrobial Agents and Chemotherapy. 2009; 53(10):4525-4528. doi: 10.1128/AAC.00223-09.
13. Hu JM, Hsiung GD. Evaluation of new antiviral agents: I. In vitro perspectives. Antiviral Research. 1989; 11(5-6):217-232. doi: 10.1016/0166-3542(89)90016-8.
14. Ghosh AP, Roth KA. Detection of Apoptosis and Autophagy. In: Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Academic Press; 2014. pp. 3841-3858. ISBN 9780123864574.
15. Viswanad V, Aleykutty N, Zachariah S, Prabhakar V. Antimicrobial Potential Of Herbal Medicines. International Journal of Pharmaceutical Sciences and Research. 2011; 2:1651-1658.
16. Cowan MM. Plant products as antimicrobial agents. Clinical Microbiology Reviews. 1999; 12(4):564-582. doi: 10.1128/CMR.12.4.564
17. Kumar K, Singh BK. Synthesis, Characterization and Anti-Microbial Activity of Some 4-Thiazolidinone Conjugatives. Asian Journal of Pharmaceutical Analysis. 2020; 10(4):195-200.
18. Maske PP, Nalavade S, Malavi SB, Jawarkar SV, Ardad RM, Lokapure SG. Synthesis and evaluation of 5, 6-dinitro and 2-dialkylaminosubstituted benzimidazoles derivatives as potential antimicrobial agents. Asian Journal of Research in Chemistry. 2015; 8(3):165-169.
19. Arun Kumar, Vinita Gupta, Sanchita Singh, Y.K. Gupta. Synthesis of Some Chalcone and Their Heterocyclic Derivatives as Potential Antimicrobial Agents: A Review. Asian J. Research Chem. 2017; 10(2):225-239.
20. Sneha U. Jadhao, Shirish P. Deshmukh. Synthesis of glycosylated-1, 2, 4-thiadiazolidines as potent antimicrobial agents. Asian J. Research Chem. 2018; 11(1):121-125.
21. Kalpana Divekar, Shivakumar Swamy, Kavitha N., V. Murugan, Manish Devgun. Synthesis and Evaluation of Some New Pyrazole Derivatives as Antimicrobial Agents. Research J. Pharm. and Tech.3 (4): Oct.-Dec.2010; Page 1039-1043.
22. Jignesh P Raval, Hemul V Patel, Pradip S. Patel, Nilesh H Patel, Kishor R Desai. A Rapid, Convenient Microwave assisted and Conventional Synthesis of novel azetidin-2-one derivatives as Potent Antimicrobial agents. Asian J. Research Chem. 2(2): April.-June, 2009 page 171-177.
23. Beena K.P., Akelesh T. A Novel Series of Dihydropyrimidines as Possible Antimicrobial Agents. Research J. Pharm. and Tech. 4(8): August 2011; Page 1252-1255.
24. Gopi K, Jayaprakashvel M. Endophytic Fungi as Potential Bioresources for the Production of Antimicrobial Agents. Research J. Pharm. and Tech. 2017; 10(11): 4111-4113.
25. S. A. Khedkar, J. S. Patil, P. M. Sabale. Design and Synthesis, In Silico Analysis of Condensed Pyrimidine derivatives as Potent Antimicrobial Agents. Research Journal of Pharmacy and Technology. 2022; 15(6):2422-6.
26. Ahmed N. Ayyash, Entesar J. Fadhil, Zainab H. Mohammad. Synthesis of Novel Bioactive compounds of 5-arylidene-2-imino-thiazolidin-4-ones as Antimicrobial agents. Research Journal of Pharmacy and Technology. 2022; 15(9):4187-1.